INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 170 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 2.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $358,917 | +112.4% | 26,725 | +215.1% | 0.00% | +100.0% |
| Q2 2021 | $169,000 | +2314.3% | 8,482 | +2542.4% | 0.00% | – |
| Q1 2021 | $7,000 | -95.1% | 321 | -86.8% | 0.00% | -100.0% |
| Q4 2017 | $142,000 | -75.1% | 2,427 | -39.3% | 0.00% | -66.7% |
| Q2 2016 | $571,000 | +836.1% | 4,001 | +1475.2% | 0.00% | – |
| Q2 2015 | $61,000 | -49.2% | 254 | -40.5% | 0.00% | -100.0% |
| Q1 2015 | $120,000 | +81.8% | 427 | +53.6% | 0.00% | – |
| Q2 2014 | $66,000 | +53.5% | 278 | +115.5% | 0.00% | – |
| Q1 2014 | $43,000 | -98.7% | 129 | -99.7% | 0.00% | -100.0% |
| Q4 2013 | $3,406,000 | +3770.5% | 49,884 | +3800.2% | 0.02% | – |
| Q3 2013 | $88,000 | +54.4% | 1,279 | 0.0% | 0.00% | – |
| Q2 2013 | $57,000 | – | 1,279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |